The effect of betamethasone dipropionate injectable on chronic bronchial asthma.

Betamethasone dipropionate was administered intramuscularly to fifty-one patients with chronic bronchial asthma. Good to excellent results were obtained in 96% of patients. Onset of action was rapid, and duration of action was prolonged. Adverse reactions were mild and transient. Decreases in early morning plasma cortisol levels were also transient with the levels returning to normal range by the end of the study in all but one patient.

Efectos del dipropionato de betametasona inyectable en el asma bronquial cronica. / Effect of injectable betamethasone dipropionate in chronic bronchial asthma

Se administro dipropionato de betametasona por via intramuscular a 51 enfermos con asma bronquial cronica.Se lograron resultados buenos a excelentes em 96% de los enfermos. La accion terapeutica se inicio rapidamente y su duracion fue prolongada. Los efectos colaterales fueron leves y pasajeros, hubo tambien reduccion pasajera de las concentraciones de cortisol plasmatico matinales y en todos, excepto en uno de los enfermos, estos volvieron a sus limites normales hacia el final del ensayo